Skip to main content
OpenTrials

Clinical trial condition

Squamous Cell Carcinoma of Head and Neck

Explore clinical trials studying Squamous Cell Carcinoma of Head and Neck. Study availability and eligibility vary by location and protocol.

1,367 public trials 360 recruiting studies
Refine in advanced search Browse all conditions

Squamous Cell Carcinoma of Head and Neck trial results

Completed

A Phase 2 Open Label Study of BA3021 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

NCT05271604

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +13 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Christiana Care Helen Graham Cancer Center Newark, Delaware, United States
  • Northwestern University Chicago, Illinois, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
View Trial Details
Completed

First In Human Study With ABBV-CLS-579 When Given Alone and In Combination In Participants With Locally Advanced Or Metastatic Tumors

NCT04417465

Conditions
Advanced Solid Tumors Cancer, Carcinoma, Carcinoma, Squamous Cell, +6 more
Locations
  • Highlands Oncology Group Springdale Springdale, Arkansas, United States
  • Yale University New Haven, Connecticut, United States
  • Fort Wayne Medical Oncology and Hematology Fort Wayne, Indiana, United States
  • Carolina BioOncology Institute Huntersville, North Carolina, United States
View all 17 locations
View Trial Details
Completed

A Study Evaluating Efficacy and Safety of Multiple Treatment Combinations in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck (Morpheus-Head and Neck Cancer)

NCT05459129

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • City of Hope Duarte, California, United States
  • Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States
  • University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
  • Hadassah University Hospital - Ein Kerem Jerusaelm, Israel
View Trial Details
Completed

A Phase 1/2 Study in Patients With HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Other Cancers

NCT04180215

Conditions
Carcinoma, Carcinoma, Squamous Cell, HPV-Related Squamous Cell Carcinoma, +13 more
Locations
  • O'Neal Comprehensive Cancer Center at UAB Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • University of Arkansas for Medical Sciences, Cancer Institute, Clinical Trials Office Fayetteville, Arkansas, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 34 locations
View Trial Details
Completed

Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors

NCT04344795

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +41 more
Locations
  • University of Colorado Aurora, Colorado, United States
  • Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine Baltimore, Maryland, United States
  • Baystate Gynecologic Oncology Springfield, Massachusetts, United States
  • University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
View Trial Details
Completed

A Study of TAK-676 With Pembrolizumab After Radiation Therapy to Treat a Number of Cancers

NCT04879849

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +18 more
Locations
  • Cedars Sinai Medical Center Duarte, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Laura And Isaac Perlmutter Cancer Center New York, United States
  • Providence Portland Medical Center Portland, Oregon, United States
View Trial Details

Related conditions